On 11 November 2015, David S. Mandell talked about why autism interventions rarely are implemented in community practice and why they fail to achieve the same outcomes as those observed in clinical trials.
On 26 September 2013, Catherine Lord and Steven Hyman presented conceptual frameworks for autism and suggest avenues to advance the field.
On 25 April 2013, Matthew State discussed genetic discoveries in autism research and the challenges that lie ahead.
On 25 January 2017, Jeremy Veenstra-VanderWeele outlined critical challenges to translating genomic, cellular, and animal model research into new treatments for autism spectrum disorder.
On 26 February 2014, David Amaral discussed different types of altered brain development among children with autism.
On 3 December 2014, Karen E. Adolph discussed how infants learn to generate and control their movements by adapting to environmental and social factors.
On 30 March 2016, Catherine Monk described her lab’s fetal origins of adult disease studies that focus on women in the perinatal period and fetal and infant neurobehavioral development, including direct studies of the fetus, newborn brain imaging and placental methylation.
Jake Gratten and Naomi Wray presented findings from the Australian Autism Biobank study, an initiative to establish an Australian resource of biospecimens, phenotypes and genomic data for autism research.
On 30 May 2013, Betty Diamond discussed immune-system-mediated alterations in brain development.
On 26 March 2014, Ami Klin presented two new infant and toddler behavioral measures of social behaviors.